What are the Historical Developments and Current Growth Metrics of the Pharma And Biotech CRM Software Market?
The pharma and biotech crm software market has seen considerable growth due to a variety of factors.
• The pharma and biotech CRM software market has experienced rapid growth in recent years. It is expected to grow from $7.39 billion in 2024 to $8.76 billion in 2025, at a compound annual growth rate (CAGR) of 18.5%.
The growth is driven by a shift toward customer-centric approaches, expanded sales and marketing channels, increased demand for data analytics, a greater need for efficiency and productivity, and an enhanced focus on customer experience.
What Is The Projected Growth Of The Pharma And Biotech CRM Software Template Market?
The pharma and biotech crm software market is expected to maintain its strong growth trajectory in upcoming years.
• The pharma and biotech CRM software market is projected to grow to $17.06 billion by 2029, with a CAGR of 18.1%.
This growth is driven by the adoption of AI-powered customer insights, virtual engagement solutions, healthcare ecosystem integration, and enhanced data security. Trends include AI-powered customer insights, predictive analytics for healthcare providers, patient-centric approaches, virtual engagement tools, and digital marketing emphasis.
What Are The Key Drivers Fueling Growth In The Pharma And Biotech CRM Software Market?
The surge in demand for personalized medical treatment is set to boost the expansion of the pharma and biotech CRM software industry in the future. Personalized treatment plans, which make use of an individual's genetic composition, environmental conditions, and lifestyle to make healthcare decisions and treat diseases, has seen an increase in popularity. This rise can be attributed to an increase in cancer rates and the escalating prevalence of chronic conditions amongst the global population. The necessity for such personalized treatments warrants the application of pharma and biotech CRM software for seamless management of patient information, monitoring treatment results, and the effective delivery of personal healthcare. To illustrate, the Personalized Medicine Coalition, a professional membership entity based in the U.S., reported that 12 novel personalized drugs were sanctioned in 2022, representing almost 34% of all new treatments, a figure greatly improving on previous years. As a result, the burgeoning demand for personalized medical approaches is fueling the expansion of the pharma and biotech CRM software market.
What Are The Principal Market Segments In The Global Pharma And Biotech CRM Software Industry?
The pharma and biotech crm software market covered in this report is segmented –
1) By Technology: Artificial Intelligence Customer Relationship Management (CRM), Conventional Customer Relationship Management (CRM)
2) By Deployment: On-Premises, Cloud Based
3) By Enterprise Size: Large Enterprise, Small And Medium Enterprise (SMEs)
4) By Industry: Pharmaceuticals, Biotech
Subsegments:
1) By Artificial Intelligence Customer Relationship Management (CRM): AI-Powered Sales Automation, AI-Driven Customer Insights And Analytics, Predictive Analytics For Lead Scoring, Chatbots And Virtual Assistants, Natural Language Processing (NLP) For Customer Interaction, Personalized Marketing And Campaign Management, Sentiment Analysis And Customer Feedback Analysis, Machine Learning For Sales Forecasting
2) By Conventional Customer Relationship Management (CRM): Contact And Lead Management, Sales Pipeline And Opportunity Management, Marketing Automation And Campaign Management, Customer Service And Support Modules, Email Marketing And Communication Tools, Customer Segmentation And Targeting, Activity Tracking And Reporting, Integration With ERP And Other Business Systems
Pre-Book The Pharma And Biotech CRM Software Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Pharma And Biotech CRM Software Market?
Top corporations in the pharmaceutical and biotech CRM software sector have been steadily integrating artificial intelligence technology and machine learning into platforms such as AI-powered personalized engagement platform. This evolution serves to meet the increasing need for sophisticated customer relationship management tools specifically designed for the pharma and biotech industries. The use of AI-powered personalized engagement permits firms to provide targeted and relevant communication to healthcare professionals, patients, and other associated parties. For example, in October 2023, Salesforce, Inc., a company from the USA that specializes in providing cloud-based software solutions, introduced its novel life sciences cloud. This platform is designed to facilitate patient interaction and clinical operations management through data, automation, and dependable AI. It empowers organizations in the pharmaceutical and medical technology fields to simplify patient engagement, clinical tasks, commercial lifecycle administration, and bespoke stakeholder experiences throughout the process of drug and device development.
Who Are the Key Players In The Pharma And Biotech CRM Software Market?
Major companies operating in the pharma and biotech CRM software market are:
• Oracle Corporation
• Salesforce.com Inc.
• IQVIA Holdings Inc.
• Trueblue Inc.
• Cirrius Solutions Inc.
• Veeva Systems Inc.
• Aurea Software Inc.
• Indegene Private Limited
• Close-Up International Limited
• Interactive Medica S.A.
• StayinFront Inc.
• Axtria Inc.
• Navicon Consulting LLC
• Aktana Inc.
• Bpmonline
• AKA Enterprise Solutions LLC
• Anthill Agency Ltd.
• Media-Soft Inc.
• Zephyr Health Inc.
• Synergistix Inc.
• Euris S.A.
• Inova Software Inc.
• Prolifiq Software Inc.
• Infonis International Corp.
• Ivy Software Development Services Pvt. Ltd.
What Are The Regional Insights Into The Pharma And Biotech CRM Software Market?
North America was the largest region in the pharma and biotech CRM software market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma and biotech crm software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
